The complex and highly specialized data abstraction includes a comprehensive understanding of, but not limited to, cancer case reportability (tumor sites and histology), patient work up/evaluations (history and physical, scans, laboratory tests, genetics testing, molecular markers, pathology reports), first course of treatment (applicable surgery, medical oncology, radiation oncology, palliative treatment) and yearly patient follow up for current cancer and vital status. Requires applying continually advancing, evidence-based treatment guidelines to collect, abstract, analyze and report cancer data as required by the States of Oregon and Washington law, and as defined by the Commission on Cancer (CoC) and Legacy Cancer Institute.